|
Source: FDA, 6/23/22 Today, the U.S. Food and Drug
Administration issued marketing denial orders (MDOs) to
JUUL Labs Inc. for all of their products currently marketed in the United
States. As a result, the company must stop selling and distributing these
products. In addition, those currently on the U.S. market must be removed, or
risk enforcement action. The products include the JUUL device and four types of
JUULpods: Virginia tobacco flavored pods at nicotine concentrations of 5.0% and
3.0% and menthol flavored pods at nicotine concentrations of 5.0% and 3.0%.
Retailers should contact JUUL with any questions about products in their
inventory.“Today’s action is further progress on the FDA’s commitment to ensuring that all e-cigarette and electronic nicotine delivery system products currently being marketed to consumers meet our public health standards,” said FDA Commissioner Robert M. Califf, M.D. “The agency has dedicated significant resources to review products from the companies that account for most of the U.S. market. We recognize these make up a significant part of the available products and many have played a disproportionate role in the rise in youth vaping.”
|